Bottom line
How much do PINK and QAAGZX overlap?
41% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 40.1% of PINK's assets and 46.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
QAAGZX holds far more positions (277 vs 54), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PINK and QAAGZX have in common
| Holding | % of PINK | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 5.91% | 14.06% | 5.91% |
| Unitedhealth Group Inc UNH | 5.76% | 5.88% | 5.76% |
| Johnson & Johnson JNJ | 5.45% | 6.64% | 5.45% |
| Abbvie Inc ABBV | 4.52% | 5.12% | 4.52% |
| Thermo Fisher Scientific Inc TMO | 3.23% | 2.53% | 2.53% |
| Gilead Sciences Inc GILD | 2.87% | 2.79% | 2.79% |
| Elevance Health Inc ELV | 2.73% | 1.54% | 1.54% |
| Danaher Corp DHR | 2.28% | 1.44% | 1.44% |
| Amgen Inc AMGN | 2.12% | 1.80% | 1.80% |
| Cvs Health Corp CVS | 2.01% | 0.93% | 0.93% |
| Cardinal Health Inc CAH | 1.78% | 1.04% | 1.04% |
| Vertex Pharmaceuticals Inc VRTX | 1.45% | 2.26% | 1.45% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PINK
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Warby Parker Inc — 5.46%
- Jazz Pharmaceuticals Plc — 4.61%
- Biohaven Ltd — 4.32%
- Benitec Biopharma Inc — 3.75%
- Align Technology Inc — 3.14%
- 10x Genomics Inc — 3.13%
- Quest Diagnostics Inc — 2.94%
- Astrazeneca Plc — 1.81%
- Establishment Labs Holdings Inc — 1.45%
- Eyepoint Inc — 1.44%
Only in QAAGZX
- Merck & Co. Inc. — 4.00%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
- Intuitive Surgical Inc — 1.89%
- Stryker Corp — 1.78%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.22%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | PINK | QAAGZX |
|---|---|---|
| Stocks | 99.6% | 96.9% |
| Preferred stock | — | 2.2% |
| Cash & short-term funds | 0.4% | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | PINK | QAAGZX |
|---|---|---|
| US | 81.0% | 92.3% |
| DK | 6.8% | 0.7% |
| VG | 5.8% | — |
| IE | 4.7% | 0.8% |
| GB | 1.8% | 1.8% |
| NL | — | 1.0% |
| BM | — | 0.7% |
| CA | — | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PINK and QAAGZX overlap?
What stocks do PINK and QAAGZX have in common?
Should I own both PINK and QAAGZX?
Which holds more stocks, PINK or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.